ANGO - AngioDynamics Inc. Company Cash on Hand

Free cash flow on the GURU.Markets chart demonstrates current liquidity, where the metric holds at 0.03. AngioDynamics, Inc. (ANGO) relies on strict FDA certification and patent protection of its devices to maintain capital stability. Demand resilience ensures the business remains non-cyclical due to the nature of life-critical procedures. The company is currently focusing on the organic growth of its oncology unit while divesting from low-profit assets.
AngioDynamics (ANGO) - metric breakdowns and financial figures

Cash holdings measure a company's immediate liquidity, determining the volume of funds available for the prompt settlement of obligations. An increase in this metric signals financial stability, whereas a sharp decline indicates a risk of capital deficiency. By analyzing the level of cash capital, an investor observes the real accumulation trend between quarterly reports. For AngioDynamics, Inc. (ANGO), this confirms the effective implementation of NanoKnife oncology platforms and the stabilization of business margins.